An interventional study of Heritage art programme in Mild Cognitive Impairment (MCI), Ageing and Mild Dementia, sponsored by Duke-NUS Graduate Medical School. Completed at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Cognitive Dysfunction with a site in Singapore — 10 open to participants now, 12 under way, 1 of them phase 3. Cognitive Dysfunction · Singapore.
Among the 42 studies in Cognitive Dysfunction with a site in Singapore, this one is the 17th largest by enrollment of the 39 interventional ones that give a count, is one of 4 that started in 2025, is one of 23 with no phase, and was the 34th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →10 of the 42 studies in Cognitive Dysfunction with a site in Singapore are open now. Recruiting first, the newest first:
National Heart Centre Singapore · Sites in Singapore
Ages 21–99
National Cancer Centre, Singapore · Sites in Singapore
Ages 50–99
Eli Lilly and Company · Sites in Singapore, United States, Australia and 1 more country
Ages 50–85
National University Hospital, Singapore · Sites in Singapore
Ages 45+
National University of Singapore · Sites in Singapore
Ages 60–85 · Healthy volunteers
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 8 · Phase 3 5 · Phase 4 2
First in 2003; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 108 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 82 across the 39 interventional studies, 236 across the 3 observational. Of the 21 that completed or were terminated, 5 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 42 have an industry lead sponsor. The 10 most frequent:
Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Duke-NUS Graduate Medical School has 5 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
4 of the studies in Cognitive Dysfunction with a site in Singapore that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT07081282National University of SingaporePrecision Stratification for Frailty and Cognitive Decline | 2027-01-31 |
| NCT07598370Eli Lilly and CompanyA Study of LY3439539 in Participants With Alzheimer's Disease | 2027-08 |
| NCT07234357National Cancer Centre, SingaporeSensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia | 2027-11 |
Add all 4 to your calendar (.ics) → With an account.
Among the 42 studies in Cognitive Dysfunction with a site in Singapore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Dementia and mild cognitive impairment are a rising concern for the ageing population in Singapore, leading to diminished quality of life and health outcomes. Arts-based interventions in a museum setting have been shown to improve cognitive health and well-being for Persons with Cognitive Impairment (PWCIs), however little is known about the relationship of heritage-based interventions on the health and well-being of PWCIs.
This mixed-methods study evaluates the 6-week "Refresh and Reconnect!" programme (R\&R!), a museum-based heritage programme including guided artist-led activities and tours of the National Museum of Singapore.
(i) In the quantitative study (n = 64-120 PWCIs, comprising with mild cognitive impairment (MCI) or mild dementia), assessments will be conducted at 2 time points (pre-programme, post-programme) to evaluate change in cognitive, social, and mental well-being.
ii) In the qualitative study, ethnographic observations of the R\&R! programme; ethnographic interviews with staff (n= max 3), \& artists (n= max 6); and in-depth interviews with PWCIs (n=16) will be used to elicit the underlying context-mechanisms-outcomes which enable R\&R! success. Programme volunteers will also be engaged through casual or informal conversations as part of the ethnographic observations.
The study will provide valuable insights for the development of effective, non-pharmacological interventions for PWCIs. The primary objectives of the study are to (a) compare the change (before and after programme participation) in the health and well-being of PWCIs participating in the programme, and (b) assess the change (before and after programme participation) in the perception of the museum, 'heritage' and learning among PWCIs participating in the programme. The secondary aims are to understand the factors, contexts, and mechanisms that influence the implementation of the museum-based intervention and its effects, including the place-based effects of the curated museum Reunion space for PWCIs.
Achieving the objectives will help answer the following research questions:
These findings are of significant public health importance for Singapore, potentially informing policy decisions, resource allocation, and healthcare strategies to better support PWCIs, ultimately improving their quality of life. Findings of the study may also contribute to similar heritage-based programmes in future, contributing to the understanding of key elements of programme success, and for whom these programmes are effective for.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Persons with cognitive impairment will undergo a 6-week heritage-based intervention programme conducted by the National Museum of Singapore, which includes guided gallery tours led by the museum's Care Facilitator volunteers and artist-led hands-on activities based on various art forms.
Other: Heritage art programme
The 6-week 'Refresh and Reconnect!' programme includes guided gallery tours led by the museum's Care Facilitator volunteers and artist-led hands-on activities based on various art forms (e.g. artist-led dance, art, or drama workshops).
Also known as: "Refresh and Reconnect!"
Change from baseline in Quality of life at the end of the 6-week intervention
Quality of life (QoL) will be assessed using the Control, Autonomy, Self-Realization, and Pleasure-11-SG (CASP-11-SG) scale. CASP-11-SG has been validated in Singapore. It has 11 items covering two domains: Control-Autonomy, and Self-realization-Pleasure (Table 1). Items are scored on a four-point response scale \[Often (score = 3), Sometimes, Not Often, Never (score = 0)\] based on how often the participant feels the way described in the item. Negatively worded items are reverse-coded. A higher total score (range: 0-33) indicates higher QoL. Control-Autonomy subscale (range: 0-18) and Self-realization-Pleasure subscale (range: 0-15) scores are also calculated.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in Health-related Quality of life at the end of the 6-week intervention
Health-related Quality of life (HRQoL) will be assessed using the EuroQol- 5 Dimension (EQ-5D) questionnaire. The EQ-5D comprises five questions on mobility, self-care, pain, usual activities, and psychological status with five possible answers for each item (1=no problem, 2=slight problem, 3=moderate problem, 4=severe problem, 5=unable to do). Overall, a total score of 5 indicates the best health state, whereas higher scores indicate more severe or frequent problems. In addition, there is a visual analogue of the scale to indicate general health status, with a score of 100 indicating the best health status.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in depression at the end of the 6-week intervention
Depression will be assessed using the CES-D-11 (Center for Epidemiologic Studies Depression Scale - 11 item version). It is a self-reported rating scale of 11 items on a 3-point Likert scale (range 0-2), with response options for "None/Rarely" (0), "Sometimes" (1), and "Often" (2) based on experiences over the past week. The total score is the sum of the 11 items, ranging from 0 to 22. Reverse Scoring: Positively worded items (e.g., "I felt happy," "I enjoyed life") are reverse scored before summing the total score. For these items, the scoring is: Often (0), Sometimes (1), None/Rarely (2). Scores of ≥9 indicate significant depressive symptoms, 5-8 suggest borderline depressive symptoms, and 0-4 fall within the normal range.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in anxiety at the end of the 6-week intervention
Anxiety will be assessed using the GAD-7 (Generalized Anxiety Disorder-7) Scale. It is a self-reported rating scale consisting of 7 items on a 4-point Likert scale (range 0-3), with response options for "Not at all" (0), "Several days" (1), "More than half the days" (2), and "Nearly every day" (3), based on experiences over the past two weeks. The total score is the sum of the 7 items, ranging from 0 to 21. Higher scores indicate greater anxiety severity. Interpretation: Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety. A total score of ≥10 is typically used as the threshold for identifying probable generalized anxiety disorder.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in loneliness at the end of the 6-week intervention
Loneliness will be assessed using The Three-Item Loneliness Scale. Each item of the scale has a five-point Likert response option: "Always" (scored as 4) "Fairly Often" (3), "Occasionally" (2), "Rarely" (1), and "Never" (scored as 0). The scores for each individual question can be added together to give a possible range of scores from 0 to 12. Higher scores indicate greater degrees of loneliness.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in social isolation at the end of the 6-week intervention
Lubbens Social Network Scale 6-item (LSNS-6) is a social engagement scale that consists of six items. The score for each item ranges from 0 to 5, with 0 indicating none and 5 indicating nine or more. The total score is calculated by finding the sum of all items, and ranges from 0 to 30. A higher score indicates more social engagement.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in ageing perceptions at the end of the 6-week intervention
The Brief Ageing Perceptions Questionnaire (Brief-APQ) measure comprise Likert scale items that represent seven ageing perception domains. Participants rate their agreement with a series of statements - for example "I am always aware of my age" or "As I get older I can take part in fewer activities" with a five-point response scale with the options: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree.
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in motivations to learn at the end of the 6-week intervention
Motivations to learn will be assessed using the Readiness-to-learn Scale from the background questionnaire of the Programme for the International Assessment of Adult Competencies (PIAAC). This scale assesses participants' motivations to learn, and the learning strategies they adopt to solve challenges in learning. The response categories for this item range from not at all (1), to a very high extent (5).
Time frame: From enrolment to the end of intervention at 6 weeks
Change from baseline in Montreal Cognitive Assessment score at the end of the 6-week intervention
Cognitive performance will be assessed using the Montreal Cognitive assessment (MoCA). MoCA assessment parameters are visuospatial/ executive, naming ability, vigilance, verbal fluency, delayed recall, and abstractions. The maximum MoCA score is 30 points. MCI (Mild Cognitive Impairment) is indicated by a score of less than 27 for those with 10 or more years of education or a score of less than 26 for those with less than 10 years of education (following the recommendation of MoCA use in Singapore).
Time frame: From enrolment to the end of intervention at 6 weeks
Changes to subjective well-being after each session of the 6-week intervention
Museum-based subjective well-being will be assessed by University College London (UCL) Museum Wellbeing Measures toolkit. The toolkit includes a 12-item Generic Wellbeing Questionnaire (GWQ) and Positive Wellbeing Measures Umbrella, designed specifically for museum projects. The GWQ uses statements that refer to an emotion or life quality that participants might have experienced during the museum activity, such as 'I felt confident'. These are rated from 1 ('None of the time') to 5 ('All of the time'). The Positive Wellbeing Umbrella consist of a hexagonal shape with six sections of different colours. Each of the six sections has a word next to it related to a wellbeing mood or emotion and responses are ranged from one (I don't feel) to five (I feel extremely). Participants are required to rate the extent they feel the wellbeing word at that moment in time by circling the appropriate number.
Time frame: From enrolment to the end of intervention at 6 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — The investigator team will decide on sharing of individual participant data on a case-to-case basis, when such requests are made.
Ran from Jan 2025 to primary completion in May 2026, 16 months.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 16 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke-NUS Graduate Medical School